LGND Stock Analysis Overview
What this means: InvestorsObserver gives Ligand Pharm (LGND) an overall rank of 46, which is below average. Ligand Pharm is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. A rank of 46 means that 54% of stocks appear more favorable to our system.
Who this matters to: Overall Ranking is a comprehensive evaluation. It considers technical and fundamental factors and is a good starting point for evaluating a stock.
LGND Fundamental Analysis
Upgrade to Premium to unlock Fundamental Ranking
LGND Short-Term Technical Analysis
Upgrade to Premium to unlock Short-Term Technical Ranking
LGND Long-Term Technical Analysis
Upgrade to Premium to unlock Long-Term Technical Ranking
LGND Analyst Ranking
Upgrade to Premium to unlock Analyst Ranking Analysis
LGND Valuation Ranking Analysis
Upgrade to Premium to unlock Valuation Ranking
LGND Stock Sentiment Analysis
Upgrade to Premium to unlock Stock Sentiment Ranking
LGND Stock Analysis Overview
What this means: InvestorsObserver gives Ligand Pharm (LGND) an overall rank of 46, which is below average. Ligand Pharm is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. A rank of 46 means that 54% of stocks appear more favorable to our system.
Who this matters to: Overall Ranking is a comprehensive evaluation. It considers technical and fundamental factors and is a good starting point for evaluating a stock.